MENU
JAZZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Jazz Pharmaceuticals (JAZZ) Earnings Date & Reports
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
JAZZ is expected to report earnings to rise 13.13% to $6.46 per share on November 11
Q3'26
Est.
$6.46
Q2'26
Missed
by $0.47
Q1'26
Beat
by $1.72
Q4'25
Beat
by $0.25
Q3'25
Beat
by $2.20
The last earnings report on August 03 showed earnings per share of $5.71, missing the estimate of $6.18. With 209.02K shares outstanding, the current market capitalization sits at 15.96B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2890
Web
https://www.jazzpharmaceuticals.com